Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

BHB making progress on two new oncologists to Bermuda

BHB is close to bringing two new oncologists to Bermuda. The new oncologists are in the final stages of recruitment having completed their local registration with the Bermuda Medical Council and we are in the process of securing immigration approval.

Following the departure of Acting Director of Oncology Dr Michael Hawking in September, BHB has one full time oncologist until the new appointees arrive.  Urgent work continues with overseas partners in order to refer newly diagnosed patients for consultation and treatment during this transition period, until the on-island Oncology service is able to have those patients transition back to Bermuda for continued treatment and follow up.

New patients with insurance will be referred overseas following a review by the Tumour Board, and we will work on individual solutions with patients who do not have insurance or cannot travel.

Acting Chief of Staff Anna Nielson-Williams comments: “We understand that our oncology patients will be very concerned about what this means to their treatment, and we recognise patients with newly discovered cancers during this time may worry about what this means to their care.

“There are up to 300 oncology patients seen by the service each month, and existing patients will continue with their chemotherapy treatments, though some appointments with the oncologist may be rescheduled for patients who are stable.

“We will do all we can to facilitate overseas referrals as quickly as possible for patients newly diagnosed until we can either secure more locum coverage or the new oncologists arrive. We will work individually with patients who do not have the option of travelling overseas.”

“A cancer diagnosis is extremely stressful for patients and families, so we apologise for the additional anxiety caused and will continue to do everything possible to ensure we can return to delivering on-island care for all.”

Any content which is considered unsuitable, unlawful, or offensive, includes personal details, advertises or promotes products, services or websites, or repeats previous comments will be removed.

User comments posted on this website are solely the views and opinions of the comment writer and are not a representation of or reflection of the opinions of TNN or its staff.

TNN reserves the right to remove, edit or censor any comments.

TNN accepts no liability and will not be held accountable for the comments made by users.